1. Induction therapy with Erlotinib (E) and Gemcitabine/Platinum (GP) in stage III NSCLC
   Overbeck Tobias R et al, 2021, Journal of Pulmonology and Respiratory Research CrossRef
2. EGFR Q787Q Polymorphism Is a Germline Variant and a Prognostic Factor for Lung Cancer Treated With TKIs
   Wen-Jui Wu et al, 2022, Frontiers in Oncology CrossRef
3. The Effects of EGFR Exon 19 747–750 Deletion on the Risk of Developing Lung Cancer
   Duygu Yolal Ertural et al, 2019, Medical Science and Discovery CrossRef